SCHEMBL9988410

SCHEMBL9988410

CC(C)(Sc1ccncc1-c1ccc(C#N)cc1)C(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ SLC22A12 Q96S37 20/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21727938 0.90 SLC22A12 (0.82) SLC22A12
SCHEMBL9988006 0.90 SLC22A12 (1.00) SLC22A12
Methyl Alcohol SCHEMBL15463509 0.89 SLC22A12 (0.98) SLC22A12
SCHEMBL12069509 0.86 SLC22A12 (1.00) SLC22A12
SCHEMBL17540588 0.85 SLC22A12 (0.74) SLC22A12
SCHEMBL12069492 0.85 SLC22A12 (1.00) SLC22A12
SCHEMBL12069496 0.84 SLC22A12 (1.00) SLC22A12
SCHEMBL12069493 0.84 SLC22A12 (1.00) SLC22A12
SCHEMBL12069491 0.84 SLC22A12 (1.00) SLC22A12
SCHEMBL12069312 0.84 SLC22A12 (1.00) SLC22A12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210171466-A1 THIOACETATE COMPOUNDS, COMPOSITIONS AND METHODS OF USE AREDEA BIOSCIENCES, INC. 2021-06-10 — — US disclosed
US-20210171466-A1 THIOACETATE COMPOUNDS, COMPOSITIONS AND METHODS OF USE AREDEA BIOSCIENCES, INC. 2021-06-10 — — US disclosed
US-10919858-B2 Thioacetate compounds, compositions and methods of use ARDEA BIOSCIENCES, INC (US) 2021-02-16 — — US disclosed
US-10919858-B2 Thioacetate compounds, compositions and methods of use ARDEA BIOSCIENCES, INC (US) 2021-02-16 — — US disclosed
EP-3611167-A1 THIOACETATE COMPOUND AND METHODS OF USE Ardea Biosciences, Inc. (US) 2020-02-19 — — EP disclosed
EP-3611167-A1 THIOACETATE COMPOUND AND METHODS OF USE Ardea Biosciences, Inc. (US) 2020-02-19 — — EP disclosed
US-20190185431-A1 THIOACETATE COMPOUNDS, COMPOSITIONS AND METHODS OF USE ARDEA BIOSCIENCES, INC. 2019-06-20 — — US disclosed
US-20190185431-A1 THIOACETATE COMPOUNDS, COMPOSITIONS AND METHODS OF USE ARDEA BIOSCIENCES, INC. 2019-06-20 — — US disclosed
US-10266493-B2 Thioacetate compounds, compositions and methods of use ARDEA BIOSCIENCES, INC. (US) 2019-04-23 — — US disclosed
US-10266493-B2 Thioacetate compounds, compositions and methods of use ARDEA BIOSCIENCES, INC. (US) 2019-04-23 — — US disclosed
US-8541589-B2 Thioacetate compounds, compositions and methods of use ARDEA BIOSCIENCES, INC. (US) 2013-09-24 — — US disclosed
US-20130203779-A1 THIOACETATE COMPOUNDS, COMPOSITIONS AND METHODS OF USE ARDEA BIOSCIENCES, INC. (US) 2013-08-08 — — US disclosed
US-20130202573-A1 THIOACETATE COMPOUNDS, COMPOSITIONS AND METHODS OF USE ARDEA BIOSCIENCES, INC. (US) 2013-08-08 — — US disclosed
US-20130202573-A1 THIOACETATE COMPOUNDS, COMPOSITIONS AND METHODS OF USE ARDEA BIOSCIENCES, INC. (US) 2013-08-08 — — US disclosed
US-20130202573-A1 THIOACETATE COMPOUNDS, COMPOSITIONS AND METHODS OF USE ARDEA BIOSCIENCES, INC. (US) 2013-08-08 — — US disclosed
US-20130203779-A1 THIOACETATE COMPOUNDS, COMPOSITIONS AND METHODS OF USE ARDEA BIOSCIENCES, INC. (US) 2013-08-08 — — US disclosed
US-20130203779-A1 THIOACETATE COMPOUNDS, COMPOSITIONS AND METHODS OF USE ARDEA BIOSCIENCES, INC. (US) 2013-08-08 — — US disclosed
EP-2585437-A2 THIOACETATE COMPOUNDS, COMPOSITIONS AND METHODS OF USE Ardea Biosciences, Inc. (US) 2013-05-01 — — EP disclosed
WO-2011159839-A2 THIOACETATE COMPOUNDS, COMPOSITIONS AND METHODS OF USE ARDEA BIOSCIENCES, INC. (US) 2011-12-22 — — WO disclosed
WO-2011159839-A2 THIOACETATE COMPOUNDS, COMPOSITIONS AND METHODS OF USE ARDEA BIOSCIENCES, INC. (US) 2011-12-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130202573-A1 THIOACETATE COMPOUNDS, COMPOSITIONS AND METHODS OF USE TXN, TXN2, XDH SLC22A12 757/4885
US-10266493-B2 Thioacetate compounds, compositions and methods of use TXN, TXN2, XDH SLC22A12 757/4885
US-20210171466-A1 THIOACETATE COMPOUNDS, COMPOSITIONS AND METHODS OF USE TXN, TXN2, XDH SLC22A12 757/4885
US-10919858-B2 Thioacetate compounds, compositions and methods of use TXN, TXN2, XDH SLC22A12 757/4885
US-20130203779-A1 THIOACETATE COMPOUNDS, COMPOSITIONS AND METHODS OF USE TXN, TXN2, XDH SLC22A12 757/4885
US-20190185431-A1 THIOACETATE COMPOUNDS, COMPOSITIONS AND METHODS OF USE TXN, TXN2, XDH SLC22A12 757/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback